274 results
8-K
EX-99.1
AZTA
Azenta Inc
8 May 24
Results of Operations and Financial Condition
4:15pm
revenue grew 3%, mainly driven by continued strength in large-automated Store Systems and Sample Repository Solutions, partially offset by a year-over-year … , flat year over year.
oOrganic revenue grew 1% year over year, primarily driven by growth in Gene Synthesis services, partially offset by a year
8-K
EX-99.1
AZTA
Azenta Inc
7 Feb 24
Results of Operations and Financial Condition
4:21pm
offset by a year-over-year decline in the C&I business. Excluding the C&I business, the segment grew 9% on an organic basis.
Multiomics revenue was $63 … services, partially offset by a year-over-year decline in Sanger sequencing revenue.
B Medical Systems revenue was $13 million, down 70% year over year
8-K
EX-99.1
quoiydamey5r xpm0nkv
13 Nov 23
Results of Operations and Financial Condition
4:30pm
8-K
EX-99.1
fw59sd
9 May 23
Azenta Reports Results of Second Quarter of Fiscal 2023 and Announces Business Realignment
4:12pm
DEFA14A
sek80bj3m
21 Dec 22
Additional proxy soliciting materials
4:07pm
8-K/A
EX-99.3
6kvg58y7gkf
15 Dec 22
Financial Statements and Exhibits
4:52pm
8-K
EX-10.1
yox8rvxlr
23 Nov 22
Azenta Announces $500 Million Accelerated Share Repurchase Agreement
7:45am
8-K
EX-99.1
u2ixdun11p q2
14 Nov 22
Azenta Reports Fourth Quarter and Full Year Fiscal 2022 Results, Authorizes $1.5 Billion Share Repurchase Program
4:44pm
8-K
EX-99.1
d4r98y5c5tqngiw30w7
9 Aug 22
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
wut6o 3zjxirsbbclks
9 May 22
Robust customer demand bolstered by operational execution drives strong second quarter results
4:11pm